Thomas A. Rawlinson

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Vaccination, Vaccine Safety, Phase 1/2 +7

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett et al. · Med · 2021 · 156 citations · Full text

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies

Ruth Payne, Sarah E. Silk, Sean C. Elias et al. · JCI Insight · 2017 · 101 citations · Full text

Rapid and iterative genome editing in the malaria parasite Plasmodium knowlesi provides new tools for P. vivax research

Franziska Mohring, Melissa N. Hart, Thomas A. Rawlinson et al. · eLife · 2019 · 95 citations · Full text

Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody

Thomas A. Rawlinson, Natalie M. Barber, Franziska Mohring et al. · Nature Microbiology · 2019 · 65 citations · Full text

Vaccination, Vaccine Target, Malaria +8